Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07342192

Radicle Clarity DSTTM: A Study Assessing the Impact of Health and Wellness Products on Mental Clarity and Related Health Outcomes

Radicle Clarity DSTTM: A Randomized, Double-Blind, Placebo-Controlled Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Mental Clarity and Related Health Outcomes

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
990 (estimated)
Sponsor
Radicle Science · Industry
Sex
All
Age
35 Years – 60 Years
Healthy volunteers
Accepted

Summary

Radicle Clarity DSTTM: A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on mental clarity and related health outcomes.

Detailed description

This is a randomized, double-blind, placebo-controlled study conducted with adult participants, residing in the United States. Eligible participants will (1) have the opportunity for meaningful improvement (at least 30%) in their primary health outcome, and (2) express acceptance in taking a product and not knowing its formulation until the end of the study. Participants that report a known cardiac dysfunction, liver or kidney disease may be excluded. Participants that report a known contraindication or with well-established, significant safety concerns due to illness will be excluded. Heavy drinkers and those who report they are pregnant, trying to become pregnant, or breastfeeding will be excluded. Participants that report taking medications with a known contraindication or with well-established, significant safety concerns will be excluded. Self-reported data are collected electronically from eligible participants for 12 weeks. Participant reports of health indicators will be collected at enrollment and throughout the active period of study product usage. All study assessments will be electronic; there are no in-person visits or assessments for this real-world evidence study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTClarity Product Placebo ControlParticipants will use their Clarity Product Placebo Control as directed for a period of 12 weeks.
DIETARY_SUPPLEMENTRS Clarity Active ProductParticipants will use their RS Clarity Active Product as directed for a period of 12 weeks

Timeline

Start date
2026-01-21
Primary completion
2027-01-21
Completion
2027-01-21
First posted
2026-01-15
Last updated
2026-01-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07342192. Inclusion in this directory is not an endorsement.